Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.72M Sell
4,900
-1,000
-17% -$356K ﹤0.01% 1716
2025
Q4
$1.93M Sell
5,900
-16,800
-74% -$5.33M 0.01% 1326
2025
Q3
$6.41M Buy
22,700
+7,400
+48% +$2.15M 0.02% 565
2025
Q2
$4.27M Buy
15,300
+8,900
+139% +$2.52M 0.02% 601
2025
Q1
$1.99M Buy
+6,400
New +$1.89M 0.01% 811
2021
Q2
Sell
-1,300
Closed -$323K 2802
2021
Q1
$323K Sell
1,300
-14,100
-92% -$3.36M ﹤0.01% 2058
2020
Q4
$3.54M Buy
+15,400
New +$3.55M 0.07% 204

Other funds holding AMGN

HRT Financial's AMGN Position: Q1 2026 in Review

HRT Financial opened a new position in Amgen (AMGN) in Q1 2026: 321,715 shares worth $113M. The stake represents 0.28% of the portfolio and ranks #49 among its holdings. This is a return to the name: HRT Financial previously reported a position in AMGN as recently as Q1 2025.

HRT Financial first reported a position in AMGN in Q3 2015 and has held it in 21 quarters since. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • HRT Financial held 321,715 shares of Amgen worth $113M as of Q1 2026.
  • Amgen was a new HRT Financial position in Q1 2026.
  • Amgen made up 0.28% of HRT Financial's portfolio in Q1 2026, its #49 holding.
  • HRT Financial first reported a position in Amgen in Q3 2015 and has held it in 21 quarters since.
  • 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.